Importantly, inhibition of NETs formation via a PAD4 inhibitor markedly downregulated GPIbα expression and alleviated disease progression in CIA, suggesting that NETs may not merely be byproducts of the inflammatory microenvironment in RA but active drivers of synovial pathology. This evidence concerns the gene PADI4 and rheumatoid arthritis.